NeRRe Therapeutics
Signal active
Organization
Contact Information
Overview
NeRRe Therapeutics Ltd. operates as a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists. The company was founded in 2012 and is based in Stevenage, United Kingdom.
About
Industries
Biotechnology, Health Care, Medical
Founded
2012
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
NeRRe Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $2.7B in funding across 36 round(s). With a team of 11-50 employees, NeRRe Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - NeRRe Therapeutics, raised $18.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$74.6M
Details
3
NeRRe Therapeutics has raised a total of $74.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 27.6M | ||
| 2017 | Early Stage Venture | 28.6M | ||
| 2012 | Early Stage Venture | 18.4M |
Investors
NeRRe Therapeutics is funded by 22 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Raj Parekh | - | FUNDING ROUND - Raj Parekh | 18.4M |
| Advent Venture Partners | - | FUNDING ROUND - Advent Venture Partners | 18.4M |
| NeRRe Therapeutics | - | FUNDING ROUND - NeRRe Therapeutics | 18.4M |
| GlaxoSmithKline | - | FUNDING ROUND - GlaxoSmithKline | 18.4M |
Recent Activity
There is no recent news or activity for this profile.